Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG9508

この論文をさがす

著者

    • KAGAMI Yoshitoyo
    • Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital
    • ITOH Kuniaki
    • Division of Hematology and Oncology, National Cancer Center Hospital East
    • TOBINAI Kensei
    • Department of Hematology, and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
    • FUKUDA Haruhiko
    • JCOG Data Center, Center for Cancer Control and Information Services, National Cancer Center
    • CHOU Takaaki
    • Department of Internal Medicine, Niigata Cancer Center Hospital
    • KINOSHITA Tomohiro
    • Department of Hematology and Oncology, Nagoya University Graduate School of Medicine,
    • FUKUSHIMA Noriyasu
    • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Saga University
    • SASAKI Tsuneo
    • Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
    • WATANABE Yuko
    • JCOG Data Center, Center for Cancer Control and Information Services, National Cancer Center
    • TSUKASAKI Kunihiro
    • Molecular Medicine Unit and Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences
    • SHIMOYAMA Masanori
    • Department of Hematology, and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
    • OGURA Michinori
    • Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital

収録刊行物

  • International journal of hematology

    International journal of hematology 96(1), 74-83, 2012-07-01

参考文献:  27件中 1-27件 を表示

各種コード

  • NII論文ID(NAID)
    10030954577
  • NII書誌ID(NCID)
    AA10797094
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    09255710
  • データ提供元
    CJP書誌 
ページトップへ